DOCHERTY JOHN MARTIN 4
4 · Lexaria Bioscience Corp. · Filed Sep 4, 2018
Insider Transaction Report
Form 4
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
- Award
Common Shares
2018-08-31$2.07/sh+36,500$75,555→ 1,622,250 total(indirect: Private holding company)
Holdings
- 850,000
Stock Options
Exercise: $0.11From: 2016-04-15Exp: 2021-04-15→ Common Shares (300,000 underlying) - 1,585,750(indirect: Private holding company)
Common Shares
- 550,000
Stock Options
Exercise: $0.09From: 2015-03-26Exp: 2020-03-26→ Common Shares (550,000 underlying) - 1,250,000
Stock Options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (400,000 underlying)